MVP is also involving in several intracellular signal cascades, e.g., mTOR/AKT, EGFR/PI3K, as a result to promote drug resistance in cancer cells (Chung et al., 2005; Wojtowicz et al., 2017). This evidence concerns the gene MVP and cancer.